119 related articles for article (PubMed ID: 35506271)
1. Prognostic value of fluorodeoxyglucose positron emission tomography derived metabolic parameters and textural features in pediatric sarcoma.
Aydos U; Sever T; Vural Ö; Topuz Türkcan B; Okur A; Akdemir ÜÖ; Poyraz A; Pinarli FG; Atay LÖ; Karadeniz C
Nucl Med Commun; 2022 Jul; 43(7):778-786. PubMed ID: 35506271
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Values of Primary Tumor Textural Heterogeneity and Blood Biomarkers in High-risk Neuroblastoma.
Vural O; Aydos U; Okur A; Pinarli FG; Atay LÖ
J Pediatr Hematol Oncol; 2023 Oct; 45(7):383-391. PubMed ID: 37027243
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Metabolic Parameters and Textural Features in Pretreatment
Wang G; Si Y; Liu J; Wang W; Yang J
Acad Radiol; 2024 Mar; 31(3):1091-1101. PubMed ID: 37748956
[TBL] [Abstract][Full Text] [Related]
4. The value of metabolic parameters and textural analysis in predicting prognosis in locally advanced cervical cancer treated with chemoradiotherapy.
Pedraza S; Seiffert AP; Sarandeses P; Muñoz-Lopez B; Gómez EJ; Sánchez-González P; Pérez-Regadera JF
Strahlenther Onkol; 2022 Sep; 198(9):792-801. PubMed ID: 35072751
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of intratumoral heterogeneity of preoperative
Kim BS; Kim SJ
Hell J Nucl Med; 2021; 24(3):172-177. PubMed ID: 34901957
[TBL] [Abstract][Full Text] [Related]
6. Can pretreatment
Song H; Jiao Y; Wei W; Ren X; Shen C; Qiu Z; Yang Q; Wang Q; Luo QY
Eur Radiol; 2019 Jul; 29(7):3945-3954. PubMed ID: 30859285
[TBL] [Abstract][Full Text] [Related]
7. Predicting neo-adjuvant chemotherapy response and progression-free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F-18 FDG PET/CT and diffusion-weighted MR imaging.
Yoon HJ; Kim Y; Chung J; Kim BS
Breast J; 2019 May; 25(3):373-380. PubMed ID: 29602210
[TBL] [Abstract][Full Text] [Related]
8. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
9. Baseline
Aide N; Fruchart C; Nganoa C; Gac AC; Lasnon C
Eur Radiol; 2020 Aug; 30(8):4623-4632. PubMed ID: 32248365
[TBL] [Abstract][Full Text] [Related]
10. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Functional Parameters of
Wang M; Xu H; Xiao L; Song W; Zhu S; Ma X
Contrast Media Mol Imaging; 2019; 2019():2641627. PubMed ID: 31427906
[TBL] [Abstract][Full Text] [Related]
12. Role of Textural Analysis of Pretreatment
Mishra A; Ravina M; Kote R; Kumar A; Kashyap Y; Dasgupta S; Reddy M
Indian J Nucl Med; 2023; 38(3):255-263. PubMed ID: 38046976
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral heterogeneity in
Molina-García D; García-Vicente AM; Pérez-Beteta J; Amo-Salas M; Martínez-González A; Tello-Galán MJ; Soriano-Castrejón Á; Pérez-García VM
Ann Nucl Med; 2018 Jul; 32(6):379-388. PubMed ID: 29869770
[TBL] [Abstract][Full Text] [Related]
14. Association of
Önner H; Coskun N; Erol M; Eren Karanis Mİ
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(1):11-16. PubMed ID: 34991831
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
Völker T; Denecke T; Steffen I; Misch D; Schönberger S; Plotkin M; Ruf J; Furth C; Stöver B; Hautzel H; Henze G; Amthauer H
J Clin Oncol; 2007 Dec; 25(34):5435-41. PubMed ID: 18048826
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.
Hwang JP; Lim I; Kong CB; Jeon DG; Byun BH; Kim BI; Choi CW; Lim SM
PLoS One; 2016; 11(4):e0153281. PubMed ID: 27100297
[TBL] [Abstract][Full Text] [Related]
17. Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET.
Sobic Saranovic DP; Nikitovic M; Saponjski J; Grozdic Milojevic I; Paripovic L; Saranovic D; Beatovic S; Artiko VM
Eur J Radiol; 2020 Aug; 129():109076. PubMed ID: 32446127
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Prognostic Role of 18F-FDG PET/CT in Pediatric Ewing Sarcoma.
Albano D; Dondi F; Schumacher RF; D'Ippolito C; Porta F; Giubbini R; Bertagna F
J Pediatr Hematol Oncol; 2020 Mar; 42(2):e79-e86. PubMed ID: 31135716
[TBL] [Abstract][Full Text] [Related]
19. Texture Analysis Using Preoperative Positron Emission Tomography Images May Predict the Prognosis of Patients With Resectable Oral Squamous Cell Carcinoma.
Kimura M; Kato I; Ishibashi K; Sone Y; Nagao T; Umemura M
J Oral Maxillofac Surg; 2021 May; 79(5):1168-1176. PubMed ID: 33428864
[TBL] [Abstract][Full Text] [Related]
20. Zone-size nonuniformity of 18F-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer.
Cheng NM; Fang YH; Lee LY; Chang JT; Tsan DL; Ng SH; Wang HM; Liao CT; Yang LY; Hsu CH; Yen TC
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):419-28. PubMed ID: 25339524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]